Westpac Banking Corp’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $151K | Sell |
994
-44
| -4% | -$6.68K | 0.01% | 379 |
|
2025
Q1 | $156K | Sell |
1,038
-34
| -3% | -$5.12K | 0.01% | 359 |
|
2024
Q4 | $198K | Sell |
1,072
-44
| -4% | -$8.12K | 0.01% | 370 |
|
2024
Q3 | $220K | Buy |
+1,116
| New | +$220K | 0.01% | 363 |
|
2023
Q2 | – | Sell |
-4,303
| Closed | -$868K | – | 562 |
|
2023
Q1 | $868K | Hold |
4,303
| – | – | 0.01% | 676 |
|
2022
Q4 | $938K | Hold |
4,303
| – | – | 0.01% | 623 |
|
2022
Q3 | $847K | Hold |
4,303
| – | – | 0.01% | 650 |
|
2022
Q2 | $921K | Hold |
4,303
| – | – | 0.01% | 680 |
|
2022
Q1 | $1.22M | Hold |
4,303
| – | – | 0.01% | 660 |
|
2021
Q4 | $1.62M | Hold |
4,303
| – | – | 0.02% | 613 |
|
2021
Q3 | $1.78M | Hold |
4,303
| – | – | 0.02% | 608 |
|
2021
Q2 | $1.59M | Buy |
+4,303
| New | +$1.59M | 0.02% | 656 |
|